Mice in which the ALKF1174L hotspot mutation and MYCN are co-expressed (Th-ALKF1174L/MYCN) develop neuroblastoma resistant to treatment with crizotinib (Berry et al., 2012). The gene discussed is MYCN; the disease is neuroblastoma.